MoneyWorks4Me

Biocon - Quaterly Results

08 Aug 2024 Evaluate
The revenue for the June 2024 quarter is pegged at Rs. 5106.00 millions against Rs. 5132.00 millions recorded during the year-ago period.Net profit was down at Rs. 9.00  millions against Rs. 466.00 millions recorded in the corresponding quarter a year ago.The net profit spiraled down by -98.07%.Operating Profit reported a sharp decline to 868.00 millions from 1080.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 5106.00 5132.00 -0.51 5106.00 5132.00 -0.51 21273.00 19929.00 6.74
Other Income 419.00 360.00 16.39 419.00 360.00 16.39 1930.00 2714.00 -28.89
PBIDT 868.00 1080.00 -19.63 868.00 1080.00 -19.63 4557.00 2949.00 54.53
Interest 552.00 483.00 14.29 552.00 483.00 14.29 1988.00 696.00 185.63
PBDT 316.00 794.00 -60.20 316.00 794.00 -60.20 2714.00 30881.00 -91.21
Depreciation 305.00 298.00 2.35 305.00 298.00 2.35 1211.00 1169.00 3.59
PBT 11.00 496.00 -97.78 11.00 496.00 -97.78 1503.00 29712.00 -94.94
TAX 2.00 30.00 -93.33 2.00 30.00 -93.33 310.00 1228.00 -74.76
Deferred Tax -22.00 -9.00 144.44 -22.00 -9.00 144.44 159.00 -99.00 -260.61
PAT 9.00 466.00 -98.07 9.00 466.00 -98.07 1193.00 28484.00 -95.81
Equity 6003.00 6003.00 0.00 6003.00 6003.00 0.00 6003.00 6003.00 0.00
PBIDTM(%) 17.00 21.04 -19.22 17.00 21.04 -19.22 21.42 14.80 44.76
Peers
Company Name CMP
Sun Pharma. Inds. 1795.85
Dr. Reddys Labs. 1195.45
Cipla 1327.05
Lupin 2019.50
Zydus Lifesciences 1141.60
View more..